Please login to the form below

Not currently logged in
Email:
Password:

clinical trials directive

This page shows the latest clinical trials directive news and features for those working in and with pharma, biotech and healthcare.

ABPI says UK role as clinical trial hub threatened by Brexit

ABPI says UK role as clinical trial hub threatened by Brexit

Others have argued the UK would benefit from leaving the EU as it would free the country from compliance with the unpopular Clinical Trials Directive (CTD), which has been criticised for ... We know the old Clinical Trials Directive did not function

Latest news

  • Safeguarding European research Safeguarding European research

    application. Moreover, in contrast with the former Directive, the EU Clinical Trials Regulation will see the introduction of a streamlined application procedure via a single entry point, the EU portal. ... Industry supports the provisions related to

  • Brexit: Medical research and the EU referendum Brexit: Medical research and the EU referendum

    On 20 May, International Clinical Trials Day, we look at how the referendum could affect research in the UK. " /. ... Many who would like to leave the EU cite the 2004 Clinical Trials Directive (CTD) as a major factor for this view.

  • Pharma slammed by MPs for withholding trial data Pharma slammed by MPs for withholding trial data

    The panel concludes that information is routinely withheld from doctors and researchers on clinical trials and - tellingly - suggests that "none of the latest proposals from regulators or industry adequately addresses the ... The European Medicines

  • MEPs agree clinical trial regulation revision MEPs agree clinical trial regulation revision

    wide database for all clinical trials of new medicines, a simplified trial application procedure via a single web portal and streamlined protocols for review and authorisation of studies. ... It is clear that something needs to be done, given that

  • Leaked EFPIA memo reveals transparency strategy Leaked EFPIA memo reveals transparency strategy

    Agency's (EMA) plans to force companies to publish all clinical study reports for their drugs. ... But in reality, they are members of EFPIA, who have actively lobbied in the opposite direction, and supported InterMune and AbbVie in suing the EMA to

More from news
Approximately 2 fully matching, plus 23 partially matching documents found.

Latest Intelligence

  • Brexit: Implications for the pharma industry Brexit: Implications for the pharma industry

    Brexit: Implications for the pharma industry. From patents to the EMA, data protection to clinical trials, there's a lot that should be a concern. ... Clinical trials. In the EU, clinical trials for medicinal products and medical devices are currently

  • Can UK pharma rise to the post-Brexit challenge? Can UK pharma rise to the post-Brexit challenge?

    We are already seeing research collaborations halted. People. The UK pharmaceutical industry runs the risk of a ‘brain drain’as clinical research opportunities in the UK diminish. ... data. 2.The Clinical Trials Directive is currently detailed and

  • Interview: Stephan Tanda, EuropaBio Interview: Stephan Tanda, EuropaBio

    He makes the point that traditional clinical trials are not suited to the development of modern personalised medicines, which have smaller target groups, drawing attention to the large numbers needed for ... Talking about the European Commission's (EC)

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Atlantis Healthcare

Atlantis Healthcare is a global leader in optimising patient self-management. Established in 1996, we design, develop and implement scalable solutions...

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...

Infographics